Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

All News Activism M&A Podcasts Private Cos. Private Equity Restructuring Scoops & Exclusives SPACs

Page 16

Podcasts

Drinks With The Deal: Kirkland's Eric Wedel

By David Marcus
|
Published: February 17th, 2022
Kirkland debt finance partner Eric Wedel discusses the evolution of the practice and how the emergence of capital markets desks at PE sponsors has changed it.
M&A

Drinks With The Deal: Katten's Kimberly Smith

By David Marcus
|
Published: February 3rd, 2022
Kimberly Smith, head of the law firm's corporate department, discusses the current state of middle-market dealmaking, her work with family offices and increased regulatory scrutiny of even smaller deals.
M&A

CI Capital Sells Epiphany Dermatology

By Armie Margaret Lee
|
Published: February 3rd, 2022
The Deal reported in October that the PE firm was exploring a sale of the Austin, Texas-based dermatology company.
M&A

Iodine Software Adds Advent to Investor Roster

By The Deal Staff
|
Published: January 14th, 2022
The healthcare software maker, which was founded in 2010 by serial entrepreneur William Chan, is valued at more than $1 billion with the new investment.
M&A

FAT Brands Buys Twin Peaks

By Nikitha Sattiraju
|
Published: January 14th, 2022
The restaurant chain operator agrees to buy the chain of sports lodges for $300 million in cash and stock.
M&A

Deal Diary: Simpson at Work Again on Blackstone Real Estate

By David Marcus
|
Published: January 14th, 2022
Blackstone uses Simpson Thacher, Barclays and Wells Fargo on a $3.6 billion deal for Bluerock Residential, which turns to Wachtell Lipton, Kaplan Voekler, Vinson & Elkins, Morgan Stanley and Eastdil.
M&A

Audax Sells RelaDyne to American Industrial

By The Deal Staff
|
Published: January 10th, 2022
The sale of the automotive fluids distributor confirms a late November report from The Deal that the $100 million-in-Ebitda business was nearing a deal.
M&A

Arxada Wins Enviro Tech Auction

Published: December 23rd, 2021
The deal for the antimicrobial specialist anticipated in November by The Deal is the second strategic acquisition for the Bain and Cinven portfolio company since its carve-out from Lonza.
 Company
Solutions
Contact The Deal
Tel:
1-888-667-3325
International:
+1-212-224-3069
Email:
[email protected]
© 2024 The Deal.

Part of the Delinian Group. Terms of Use, Commercial Terms & Conditions, Privacy Policy, Accessibility, Modern Slavery Act